Experienced in Follicular Lymphoma

Josien C. Regelink

Amersfoort, UT, NL 

Experienced in Follicular Lymphoma
Amersfoort, UT, NL 
OverviewLocationsClinical Research

Overview

Josien Regelink practices in Amersfoort, Netherlands. Regelink is rated as an Experienced expert by MediFind in the treatment of Follicular Lymphoma. Their top areas of expertise are Multiple Myeloma, Hereditary Hyperekplexia, Leukemia, and Autoimmune Hemolytic Anemia.

Their clinical research consists of co-authoring 22 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Follicular Lymphoma.

Locations

Amersfoort, UT, Netherlands
Other Locations
Elisabeth TweeSteden Ziekenhuis
Tilburg, NB, Netherlands
Amsterdam, NH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3

22 Total Publications

Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome.
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome.
Journal: HemaSphere
Published: July 31, 2025
View All 22 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Regelink's expertise for a condition
ConditionClose
      • Advanced
      • Multiple Myeloma
        Regelink is
        Advanced
        . Learn about Multiple Myeloma.
        See more Multiple Myeloma experts
      • Experienced
      • Acute Myeloid Leukemia (AML)
        Regelink is
        Experienced
        . Learn about Acute Myeloid Leukemia (AML).
        See more Acute Myeloid Leukemia (AML) experts
      • Autoimmune Hemolytic Anemia
        Regelink is
        Experienced
        . Learn about Autoimmune Hemolytic Anemia.
        See more Autoimmune Hemolytic Anemia experts
      • Bone Tumor
        Regelink is
        Experienced
        . Learn about Bone Tumor.
        See more Bone Tumor experts
      • Chronic B-Cell Leukemia (CBCL)
        Regelink is
        Experienced
        . Learn about Chronic B-Cell Leukemia (CBCL).
        See more Chronic B-Cell Leukemia (CBCL) experts
      • Chronic Lymphocytic Leukemia (CLL)
        Regelink is
        Experienced
        . Learn about Chronic Lymphocytic Leukemia (CLL).
        See more Chronic Lymphocytic Leukemia (CLL) experts
      • Follicular Lymphoma
        Regelink is
        Experienced
        . Learn about Follicular Lymphoma.
        See more Follicular Lymphoma experts
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved